-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Replimune Group Analyst Ratings
Replimune Group Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
10/03/2022 | 73.71% | SVB Leerink | $37 → $30 | Maintains | Outperform |
08/16/2022 | 148.99% | Piper Sandler | $44 → $43 | Maintains | Overweight |
08/05/2022 | 114.24% | SVB Leerink | $48 → $37 | Maintains | Outperform |
05/24/2022 | 201.1% | Wedbush | $59 → $52 | Maintains | Outperform |
05/20/2022 | 177.94% | SVB Leerink | $49 → $48 | Maintains | Outperform |
04/04/2022 | 125.83% | JP Morgan | $47 → $39 | Maintains | Overweight |
03/18/2022 | 73.71% | BMO Capital | $51 → $30 | Maintains | Outperform |
11/19/2021 | 201.1% | Piper Sandler | → $52 | Initiates Coverage On | → Overweight |
08/23/2021 | 183.73% | SVB Leerink | $55 → $49 | Maintains | Outperform |
08/09/2021 | 218.47% | SVB Leerink | $56 → $55 | Maintains | Outperform |
02/05/2021 | 247.42% | HC Wainwright & Co. | $58 → $60 | Maintains | Buy |
02/04/2021 | 224.26% | SVB Leerink | $57 → $56 | Maintains | Outperform |
11/17/2020 | 247.42% | BTIG | → $60 | Initiates Coverage On | → Buy |
11/10/2020 | 235.84% | HC Wainwright & Co. | $54 → $58 | Maintains | Buy |
11/06/2020 | 230.05% | BMO Capital | $51 → $57 | Maintains | Outperform |
10/15/2020 | 195.31% | BMO Capital | $40 → $51 | Maintains | Outperform |
10/15/2020 | 212.68% | HC Wainwright & Co. | $25 → $54 | Upgrades | Neutral → Buy |
10/15/2020 | 154.78% | SVB Leerink | $27 → $44 | Maintains | Outperform |
08/07/2020 | 56.34% | SVB Leerink | $25 → $27 | Maintains | Outperform |
07/01/2020 | 44.76% | HC Wainwright & Co. | → $25 | Downgrades | Buy → Neutral |
06/04/2020 | 44.76% | HC Wainwright & Co. | $24 → $25 | Maintains | Buy |
05/05/2020 | 21.6% | Barclays | → $21 | Initiates Coverage On | → Overweight |
01/21/2020 | 38.97% | HC Wainwright & Co. | $26 → $24 | Maintains | Buy |
09/04/2019 | 15.81% | Roth Capital | → $20 | Initiates Coverage On | → Buy |
07/23/2019 | 62.13% | Chardan Capital | → $28 | Initiates Coverage On | → Buy |
07/12/2019 | 50.55% | JP Morgan | $27 → $26 | Upgrades | Neutral → Overweight |
07/08/2019 | 50.55% | HC Wainwright & Co. | → $26 | Initiates Coverage On | → Buy |
04/25/2019 | 38.97% | Wedbush | → $24 | Initiates Coverage On | → Outperform |
01/23/2019 | — | JP Morgan | Downgrades | Overweight → Neutral | |
08/14/2018 | 79.5% | BMO Capital | → $31 | Initiates Coverage On | → Outperform |
08/14/2018 | 50.55% | JP Morgan | → $26 | Initiates Coverage On | → Overweight |
Replimune Group Questions & Answers
The latest price target for Replimune Group (NASDAQ: REPL) was reported by SVB Leerink on October 3, 2022. The analyst firm set a price target for $30.00 expecting REPL to rise to within 12 months (a possible 73.71% upside). 8 analyst firms have reported ratings in the last year.
The latest analyst rating for Replimune Group (NASDAQ: REPL) was provided by SVB Leerink, and Replimune Group maintained their outperform rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Replimune Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Replimune Group was filed on October 3, 2022 so you should expect the next rating to be made available sometime around October 3, 2023.
While ratings are subjective and will change, the latest Replimune Group (REPL) rating was a maintained with a price target of $37.00 to $30.00. The current price Replimune Group (REPL) is trading at is $17.27, which is out of the analyst's predicted range.
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
10/03/2022 | 73.71% | SVB Leerink | $37 → $30 | Maintains | Outperform |
08/16/2022 | 148.99% | Piper Sandler | $44 → $43 | Maintains | Overweight |
08/05/2022 | 114.24% | SVB Leerink | $48 → $37 | Maintains | Outperform |
05/24/2022 | 201.1% | Wedbush | $59 → $52 | Maintains | Outperform |
05/20/2022 | 177.94% | SVB Leerink | $49 → $48 | Maintains | Outperform |
04/04/2022 | 125.83% | JP Morgan | $47 → $39 | Maintains | Overweight |
03/18/2022 | 73.71% | BMO Capital | $51 → $30 | Maintains | Outperform |
11/19/2021 | 201.1% | Piper Sandler | → $52 | Initiates Coverage On | → Overweight |
08/23/2021 | 183.73% | SVB Leerink | $55 → $49 | Maintains | Outperform |
08/09/2021 | 218.47% | SVB Leerink | $56 → $55 | Maintains | Outperform |
02/05/2021 | 247.42% | HC Wainwright & Co. | $58 → $60 | Maintains | Buy |
02/04/2021 | 224.26% | SVB Leerink | $57 → $56 | Maintains | Outperform |
11/17/2020 | 247.42% | BTIG | → $60 | Initiates Coverage On | → Buy |
11/10/2020 | 235.84% | HC Wainwright & Co. | $54 → $58 | Maintains | Buy |
11/06/2020 | 230.05% | BMO Capital | $51 → $57 | Maintains | Outperform |
10/15/2020 | 195.31% | BMO Capital | $40 → $51 | Maintains | Outperform |
10/15/2020 | 212.68% | HC Wainwright & Co. | $25 → $54 | Upgrades | Neutral → Buy |
10/15/2020 | 154.78% | SVB Leerink | $27 → $44 | Maintains | Outperform |
08/07/2020 | 56.34% | SVB Leerink | $25 → $27 | Maintains | Outperform |
07/01/2020 | 44.76% | HC Wainwright & Co. | → $25 | Downgrades | Buy → Neutral |
06/04/2020 | 44.76% | HC Wainwright & Co. | $24 → $25 | Maintains | Buy |
05/05/2020 | 21.6% | Barclays | → $21 | Initiates Coverage On | → Overweight |
01/21/2020 | 38.97% | HC Wainwright & Co. | $26 → $24 | Maintains | Buy |
09/04/2019 | 15.81% | Roth Capital | → $20 | Initiates Coverage On | → Buy |
07/23/2019 | 62.13% | Chardan Capital | → $28 | Initiates Coverage On | → Buy |
07/12/2019 | 50.55% | JP Morgan | $27 → $26 | Upgrades | Neutral → Overweight |
07/08/2019 | 50.55% | HC Wainwright & Co. | → $26 | Initiates Coverage On | → Buy |
04/25/2019 | 38.97% | Wedbush | → $24 | Initiates Coverage On | → Outperform |
01/23/2019 | — | JP Morgan | Downgrades | Overweight → Neutral | |
08/14/2018 | 79.5% | BMO Capital | → $31 | Initiates Coverage On | → Outperform |
08/14/2018 | 50.55% | JP Morgan | → $26 | Initiates Coverage On | → Overweight |
日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
---|---|---|---|---|---|
2022 年 3 月 10 日 | 73.71% | SVB Leerink | 37 美元 → 30 美元 | 維持 | 跑贏大盤 |
08/16/2022 | 148.99% | 派珀·桑德勒 | 44 美元 → 43 美元 | 維持 | 超重 |
08/05/2022 | 114.24% | SVB Leerink | 48 美元 → 37 美元 | 維持 | 跑贏大盤 |
2022 年 5 月 24 日 | 201.1% | Wedbush | 59 美元 → 52 美元 | 維持 | 跑贏大盤 |
05/20/2022 | 177.94% | SVB Leerink | 49 美元 → 48 美元 | 維持 | 跑贏大盤 |
2022 年 4 月 4 日 | 125.83% | 摩根大通 | 47 美元 → 39 美元 | 維持 | 超重 |
03/18/2022 | 73.71% | BMO Capital | 51 美元 → 30 美元 | 維持 | 跑贏大盤 |
11/19/2021 | 201.1% | 派珀·桑德勒 | → 52 美元 | 啓動覆蓋範圍開啓 | → 超重 |
08/23/2021 | 183.73% | SVB Leerink | 55 美元 → 49 美元 | 維持 | 跑贏大盤 |
2021 年 9 月 8 日 | 218.47% | SVB Leerink | 56 美元 → 55 美元 | 維持 | 跑贏大盤 |
02/05/2021 | 247.42% | HC Wainwright & Co. | 58 美元 → 60 美元 | 維持 | 購買 |
02/04/2021 | 224.26% | SVB Leerink | 57 美元 → 56 美元 | 維持 | 跑贏大盤 |
2020 年 11 月 17 日 | 247.42% | BTIG | → 60 美元 | 啓動覆蓋範圍開啓 | → 購買 |
11/10/2020 | 235.84% | HC Wainwright & Co. | 54 美元 → 58 美元 | 維持 | 購買 |
11/06/2020 | 230.05% | BMO Capital | 51 美元 → 57 美元 | 維持 | 跑贏大盤 |
2020 年 10 月 15 日 | 195.31% | BMO Capital | 40 美元 → 51 美元 | 維持 | 跑贏大盤 |
2020 年 10 月 15 日 | 212.68% | HC Wainwright & Co. | 25 美元 → 54 美元 | 升級 | 中性 → 買入 |
2020 年 10 月 15 日 | 154.78% | SVB Leerink | 27 美元 → 44 美元 | 維持 | 跑贏大盤 |
08/07/2020 | 56.34% | SVB Leerink | 25 美元 → 27 美元 | 維持 | 跑贏大盤 |
07/01/2020 | 44.76% | HC Wainwright & Co. | → 25 美元 | 降級 | 買入 → 中性 |
06/04/2020 | 44.76% | HC Wainwright & Co. | 24 美元 → 25 美元 | 維持 | 購買 |
05/05/2020 | 21.6% | 巴克萊 | → 21 美元 | 啓動覆蓋範圍開啓 | → 超重 |
2020 年 1 月 21 日 | 38.97% | HC Wainwright & Co. | 26 美元 → 24 美元 | 維持 | 購買 |
09/04/2019 | 15.81% | 羅斯資本 | → 20 美元 | 啓動覆蓋範圍開啓 | → 購買 |
07/23/2019 | 62.13% | 查丹資本 | → 28 美元 | 啓動覆蓋範圍開啓 | → 購買 |
07/12/2019 | 50.55% | 摩根大通 | 27 美元 → 26 美元 | 升級 | 中性 → 超重 |
07/08/2019 | 50.55% | HC Wainwright & Co. | → 26 美元 | 啓動覆蓋範圍開啓 | → 購買 |
04/25/2019 | 38.97% | Wedbush | → 24 美元 | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
2019 年 1 月 23 日 | — | 摩根大通 | 降級 | 超重 → 中性 | |
08/14/2018 | 79.5% | BMO Capital | → 31 美元 | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
08/14/2018 | 50.55% | 摩根大通 | → 26 美元 | 啓動覆蓋範圍開啓 | → 超重 |
Replimune Group Questions & Answers
Replimune 群組問題與解答
The latest price target for Replimune Group (NASDAQ: REPL) was reported by SVB Leerink on October 3, 2022. The analyst firm set a price target for $30.00 expecting REPL to rise to within 12 months (a possible 73.71% upside). 8 analyst firms have reported ratings in the last year.
SVB Leerink於2022年10月3日公佈了Replimune集團(納斯達克股票代碼:REPL)的最新目標股價。該分析公司將目標股價定爲30.00美元,預計REPL將在12個月內上漲至30.00美元(可能上漲73.71%)。去年有8家分析公司公佈了評級。
The latest analyst rating for Replimune Group (NASDAQ: REPL) was provided by SVB Leerink, and Replimune Group maintained their outperform rating.
Replimune Group(納斯達克股票代碼:REPL)的最新分析師評級由SVB Leerink提供,Replimune Group維持跑贏大盤的評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Replimune Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Replimune Group was filed on October 3, 2022 so you should expect the next rating to be made available sometime around October 3, 2023.
分析師在進行了廣泛的研究後得出了股票評級,其中包括瀏覽公開財務報表,與Replimune集團的高管和客戶交談,以及聽取業績電話會議。大多數分析師每三個月進行一次評級,因此每家公司每年應獲得4個評級。Replimune集團的最後一次評級是在2022年10月3日提交的,因此您應該預計下一個評級將在2023年10月3日左右公佈。
While ratings are subjective and will change, the latest Replimune Group (REPL) rating was a maintained with a price target of $37.00 to $30.00. The current price Replimune Group (REPL) is trading at is $17.27, which is out of the analyst's predicted range.
儘管評級是主觀的,並將發生變化,但Replimune集團(REPL)的最新評級維持不變,目標股價爲37.00美元至30.00美元。Replimune集團(REPL)目前的交易價格爲17.27美元,超出了分析師的預測區間。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧